SCHEMBL3348473

SCHEMBL3348473

NC1=NC(N)(c2ncccn2)NC=C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1172351 0.73 BACE1 (0.38)
SCHEMBL3695481 0.69
SCHEMBL1172224 0.68 BACE1 (0.32)
SCHEMBL1171736 0.67 KDM4E (0.48)
SCHEMBL1171746 0.67 CTSD (0.32)
SCHEMBL1171761 0.67 APP (0.32)
SCHEMBL1172133 0.66 BACE1 (0.39)
SCHEMBL4462368 0.65 HTR5A (0.32)
SCHEMBL9848852 0.64
SCHEMBL6204888 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101686675-A Compound (I) SMITHKLINE BEECHAM CORP 2010-03-31 CN claimed
WO-2010038081-A2 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2010-04-08 WO disclosed
CN-101686675-A Compound (I) SMITHKLINE BEECHAM CORP 2010-03-31 CN disclosed
EP-1725540-A1 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-11-29 EP disclosed
WO-2005095359-A1 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-13 WO disclosed